Vitamin B12 Deficiency after Gastric Surgery

  1. Anne E. Sumner, MD;
  2. Janet L. Abrahm, MD; and
  3. Sally P. Stabler, MD
  1. Medical College of Pennsylvania and Hahnemann University, Philadelphia, PA 19129. Philadelphia Veterans Affairs Medical Center, Philadelphia, PA 19104. University of Colorado Health Sciences Center, Denver, CO 80262.

    The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:

    •Include no more than 300 words of text, three authors, and five references

    •Type with double-spacing

    •Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.

    Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.

    Annals welcomes electronically submitted letters.

    IN RESPONSE:

    Our investigation confirms the known metabolic consequences of gastric surgery using the most sensitive available tests—measurement of serum methylmalonic acid and total homocysteine levels—to determine vitamin B12 deficiency. We did not determine the cause of vitamin B12 deficiency but agree with Drs. Murthy and Visweswaraiah that achlorhydria, intestinal blind-loop syndromes, and histamine-2 antagonist therapy could have caused some of the malabsorption. Histamine-2 antagonists are frequently prescribed and available over the counter. We did not test for food protein-bound cobalamin absorption. A limitation of all vitamin B12-absorption tests is that they only measure malabsorption at the time of the test and not whether vitamin B12 deficiency is actually present. Further, the tests are not standardized.

    Approximately 50% of the patients who had gastric surgery were inpatients and 50% were outpatients. Of the patients with vitamin B12 deficiency, 12 were outpatients, 5 were inpatients, and 2 were residents of a Veterans Affairs nursing home.

    Participants were not treated simultaneously with vitamin B12 and folate. Because we used elevation of serum methylmalonic acid levels and low or normal vitamin B12 levels as our major criteria for defining vitamin B12 deficiency, we do not believe that intake or problems in measurement of either serum or erythrocyte folate levels would have any effect on data. Only one case met the second definition of vitamin B12 deficiency (normal methylmalonic acid level and abnormal homocysteine level). Treatment with vitamin B12 decreased this patient's total homocysteine level from 22.8 µmol/L to 10.9 µmol/L. In addition to problems in standardization of the erythrocyte folate test, the test cannot distinguish between folate or vitamin B12 deficiency. Therefore, the test would not add any diagnostic information to that discovered through methylmalonic acid and homocysteine assays.

    We agree with the concerns of Drs. Murthy and Visweswaraiah that tests for serum vitamin B12 level are not specific and that if this level alone is relied on, vitamin B12 deficiency could be overdiagnosed. In our study, only 2 of 22 controls with low vitamin B12 levels had metabolic evidence of vitamin B12 deficiency. Because patients who have had gastric surgery have an increased risk for vitamin B12 malabsorption, the number who were deficient was much higher; therefore, fewer patients with normal vitamin B12 levels would be treated on the basis of only the serum vitamin B12 level. Further, overtreatment with vitamin B12 would not be harmful, and it seems unwise to risk having a patient develop possibly irreversible demyelinating disease of the nervous system or anemia. Our investigation shows the advantage of using measurement of serum methylmalonic acid and homocysteine levels with the measurement of serum vitamin B12 and folate levels to gain specificity of diagnosis and to maximize the benefits of treatment.

    Anne E. Sumner, MD

    Janet L. Abrahm, MD

    Sally P. Stabler, MD

    « Previous | Next Article »Table of Contents

    Navigate This Article

    1. Top